Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Annovis Bio Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Annovis Bio Inc. June 17, 202694.0%
-
Annovis Bio Inc. June 17, 202595.3%
-
Annovis Bio Inc. June 13, 202496.9%
-
Annovis Bio Inc. June 16, 202399.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 6, 2026 | Annovis Bio Inc. | Open-market purchase | +5,000,000 | $1.00 | $5,000,000 |
| May 20, 2026 | Annovis Bio Inc. | Open-market purchase | +2,562 | $1.75 | $4,484 |
| May 20, 2026 | Annovis Bio Inc. | Open-market purchase | +18,849 | $1.80 | $33,928 |
| May 20, 2026 | Annovis Bio Inc. | Open-market purchase | +54,933 | $1.90 | $104,373 |
| Apr 2, 2026 | Annovis Bio Inc. | Open-market purchase | +713,800 | $2.10 | $1,498,980 |
| Dec 8, 2025 | Annovis Bio Inc. | Open-market purchase | +30,000 | $4.34 | $130,200 |
| Dec 8, 2025 | Annovis Bio Inc. | Open-market purchase | +15,000 | $4.24 | $63,600 |
| Nov 24, 2025 | Annovis Bio Inc. | Open-market purchase | +1,489 | $4.13 | $6,150 |
| Nov 24, 2025 | Annovis Bio Inc. | Open-market purchase | +9,200 | $3.85 | $35,420 |
| Nov 24, 2025 | Annovis Bio Inc. | Open-market purchase | +415 | $4.14 | $1,718 |
| Nov 24, 2025 | Annovis Bio Inc. | Open-market purchase | +28,096 | $4.15 | $116,598 |
| Nov 21, 2025 | Annovis Bio Inc. | Open-market purchase | +10,000 | $3.49 | $34,900 |
| Nov 21, 2025 | Annovis Bio Inc. | Open-market purchase | +10,000 | $3.50 | $35,000 |
| Nov 14, 2025 | Annovis Bio Inc. | Open-market purchase | +15,000 | $2.11 | $31,650 |
| Oct 28, 2025 | Annovis Bio Inc. | Open-market purchase | +975,610 | $2.05 | $2,000,001 |
Questions about Michael B. Hoffman
What boards is Michael B. Hoffman on?
Michael B. Hoffman sits on the boards of Annovis Bio Inc. and Translational Development Acquisition Corp.
What company is Michael B. Hoffman the CEO of?
Michael B. Hoffman has been Chief Executive Officer of Translational Development Acquisition Corp. since December 2024.
How long has Michael B. Hoffman served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.